share_log

HC Wainwright & Co. Reiterates Buy on Nuvation Bio, Maintains $4.5 Price Target

Benzinga ·  Nov 22, 2023 06:19

HC Wainwright & Co. analyst Robert Burns reiterates Nuvation Bio (NYSE:NUVB) with a Buy and maintains $4.5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment